These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10622688)

  • 1. The use and development of anxiolytics in Japan.
    Yamawaki S
    Eur Neuropsychopharmacol; 1999 Dec; 9 Suppl 6():S413-9. PubMed ID: 10622688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone and related compounds as alternative anxiolytics.
    Taylor DP; Moon SL
    Neuropeptides; 1991 Jul; 19 Suppl():15-9. PubMed ID: 1679210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacology of anxiolytics and their therapeutic use].
    Tada K
    Ryoikibetsu Shokogun Shirizu; 2003; (38):608-11. PubMed ID: 12877061
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole HCl (MKC-242), a novel 5-HT1A-receptor agonist, on aggressive behavior and marble burying behavior in mice.
    Abe M; Nakai H; Tabata R; Saito K; Egawa M
    Jpn J Pharmacol; 1998 Mar; 76(3):297-304. PubMed ID: 9593223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin-1A anxiolytics: an overview.
    Feighner JP; Boyer WF
    Psychopathology; 1989; 22 Suppl 1():21-6. PubMed ID: 2567039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of anxiolytics, diazepam and tandospirone, on immobilization stress-induced hyperglycemia in mice.
    Sugimoto Y; Yamada J; Noma T
    Life Sci; 1998; 63(14):1221-6. PubMed ID: 9771911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of the novel anxiolytic drug lesopitron, a full and selective 5-HT1A receptor agonist, on pupil diameter and oral temperature in man: comparison with buspirone.
    Phillips MA; Szabadi E; Bradshaw CM
    J Psychopharmacol; 1999 Dec; 13(4):391-7. PubMed ID: 10667616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral studies of serotonin receptor agonists as antidepressant drugs.
    Lucki I
    J Clin Psychiatry; 1991 Dec; 52 Suppl():24-31. PubMed ID: 1684363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dementia induced by antianxiety drugs].
    Inada K; Ishigooka J
    Nihon Rinsho; 2004 Jan; 62 Suppl():461-5. PubMed ID: 15011406
    [No Abstract]   [Full Text] [Related]  

  • 10. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
    Dekeyne A; Brocco M; Adhumeau A; Gobert A; Millan MJ
    Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Although antidepressants and anxiolytics are frequently used together to treat depression in the acute phase, how effective is the concomitant use of these drugs?
    Kanba S
    J Psychiatry Neurosci; 2004 Nov; 29(6):485. PubMed ID: 15644990
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of repeated ipsapirone treatment on hippocampal excitatory synaptic transmission in the freely behaving rat: role of 5-HT1A receptors and relationship to anxiolytic effect.
    Xu L; Anwyl R; De Vry J; Rowan MJ
    Eur J Pharmacol; 1997 Mar; 323(1):59-68. PubMed ID: 9105877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
    Koek W; Patoiseau JF; Assié MB; Cosi C; Kleven MS; Dupont-Passelaigue E; Carilla-Durand E; Palmier C; Valentin JP; John G; Pauwels PJ; Tarayre JP; Colpaert FC
    J Pharmacol Exp Ther; 1998 Oct; 287(1):266-83. PubMed ID: 9765347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of 5-HT1A receptor agonists and benzodiazepine anxiolytics on the emotional state of naive and stressed mice: a study using the hole-board test.
    Tsuji M; Takeda H; Matsumiya T
    Psychopharmacology (Berl); 2000 Oct; 152(2):157-66. PubMed ID: 11057519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The serotonin- and dopaminergic mechanisms in the action of 1-pyrimidinyl piperazine derivatives].
    Abramets II; Obraztsova OG; Samoĭlovich IM; Kharin NA
    Eksp Klin Farmakol; 1992; 55(3):8-11. PubMed ID: 1360856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia.
    Sumiyoshi T; Matsui M; Yamashita I; Nohara S; Uehara T; Kurachi M; Meltzer HY
    J Clin Psychopharmacol; 2000 Jun; 20(3):386-8. PubMed ID: 10831031
    [No Abstract]   [Full Text] [Related]  

  • 17. The anxiolytic effects of the 5-hydroxytryptamine-1A agonist tandospirone before otolaryngologic surgery.
    Oshima T; Kasuya Y; Terazawa E; Nagase K; Saitoh Y; Dohi S
    Anesth Analg; 2001 Nov; 93(5):1214-6. PubMed ID: 11682400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the anxiolytic action of 5-HT1A compounds by GABA-benzodiazepine agents in rats.
    Fernández-Guasti A; López-Rubalcava C
    Pharmacol Biochem Behav; 1998 May; 60(1):27-32. PubMed ID: 9610920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of tandospirone on ataxia of a patient with Machado-Joseph disease.
    Takei A; Honma S; Kawashima A; Yabe I; Fukazawa T; Hamada K; Hamada T; Tashiro K
    Psychiatry Clin Neurosci; 2002 Apr; 56(2):181-5. PubMed ID: 11952922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.